| Typicality: | 0.561 |
| Saliency: | 0.350 |
| period → be presented in → accompanying consolidated financial statements | 7 |
| period → be presented in → consolidated financial statements | 6 |
| period → be covered by → consolidated financial statements | 5 |
| period → be included in → accompanying consolidated financial statements | 4 |
| period → be included in → accompanying consolidated balance sheets | 3 |
| negative | neutral | positive |
| 0.148 | 0.799 | 0.053 |
| Raw frequency | 25 |
| Normalized frequency | 0.350 |
| Modifier score | 1.000 |
| Perplexity | 54.704 |